利用遗传学进行青光眼筛查和风险分层:第八十二届爱德华·杰克逊纪念讲座
该讲座综述了青光眼遗传学的进展:已发现至少11个儿童青光眼致病基因和数百个影响成人开角型青光眼风险的基因组位点。儿童青光眼基因检测可指导遗传咨询和突变携带者的监测治疗,多基因风险评分与更早、更侵袭性的成人青光眼相关,可能用于风险分层和人群筛查。
要点
- 已发现至少11个儿童青光眼致病基因,基因检测可指导遗传咨询和风险管理。
- 全基因组关联研究已识别数百个影响成人开角型青光眼的遗传变异。
- 由这些风险变异构成的多基因风险评分与更早、更侵袭性的疾病相关。
核心结论
- 青光眼遗传学的最新进展为利用遗传信息指导疾病的预防、诊断和治疗提供了新机会,并最终有望实现个性化的青光眼临床诊疗。
研究设计与样本
- 观点与回顾性综述,方法为文献回顾和个人回忆。
主要发现
- 对已知儿童青光眼基因进行基因检测可指导遗传咨询,并为突变携带者制定风险匹配的监测和治疗计划。
- 儿童青光眼的总体诊断率受限于已知基因数量相对较少。
- 全基因组关联研究已识别数百个影响成人起病青光眼的遗传变异,由这些风险变异构成的多基因风险评分与更早、更侵袭性的疾病相关。
关键数值与推荐
- 儿童青光眼已知致病基因至少11个。
- 影响成人起病青光眼风险的基因组位点达数百个。
临床怎么用
- 作者认为,利用已知青光眼基因对儿童型青光眼进行基因检测可指导遗传咨询并制定风险匹配的监测和治疗计划。
- 作者认为,多基因风险评分可能有助于疾病风险分层,并可能用于人群筛查。
局限性
- 儿童青光眼的总体诊断率受限于已知基因数量相对较少。
- 支持进一步基因发现的研究仍在进行中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide an update on advances in glaucoma genetics and to describe how genetic information can be used for disease screening and risk stratification. DESIGN: Perspective and retrospective review. METHODS: Literature review and personal recollections. RESULTS: Supported by cutting-edge genetic resources and methodologies as well as collaborations, the field of glaucoma genetics has seen tremendous progress over the past 3 decades with the discovery of at least 11 genes responsible for childhood glaucoma and hundreds of genomic loci influencing adult-onset glaucoma risk. These discoveries are an important step toward a personalized treatment approach for glaucoma and particularly have created opportunities to use this genetic information for glaucoma risk stratification and disease screening. Genetic testing using known glaucoma genes for childhood forms of glaucoma can inform genetic counseling and develop risk-appropriate surveillance and treatment plans for mutation carriers. The overall diagnostic yield for childhood glaucoma is limited by the relatively small number of known genes; however, ongoing research supporting further gene discovery is promising. Hundreds of genetic variants influencing adult-onset glaucoma have been identified by genome-wide association studies, and polygenic risk scores composed of these risk variants have been associated with earlier and more aggressive disease supporting a role for polygenic risk score testing in disease risk stratification and potentially also in population screening. CONCLUSIONS: Recent advances in glaucoma genetics are providing new opportunities to use genetic information to guide prevention, diagnosis, and treatment of disease and ultimately to develop a personalized approach to glaucoma clinical care.
引用
- Wiggs JL. Using Genetics for Glaucoma Screening and Risk Stratification: The LXXXII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2025. PMID: 41075857. doi:10.1016/j.ajo.2025.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。